CDMOHUBCDMOHUB
Pricing
    CDMOHUBCDMOHUB
    Pricing
    CDMOHUBCDMOHUB
    Pricing
    CDMOHUBCDMOHUB
    Pricing
    1. Home
    2. /CDMOs
    3. /SEQENS
    SEQENS logo

    SEQENS

    CDMO
    Canada
    https://www.seqens.com/

    Is this your company? Claim this profile

    Drug Substance
    Analytical & Bioanalytical Services
    Regulatory, Tech Transfer & Support Services
    Others
    Company Overview

    About

    SEQENS is a global integrated CDMO and specialty ingredients leader with 15 production sites across 9 countries and 5 R&D centers. The company manufactures custom and generic APIs, intermediates, excipients, custom lipids for drug delivery (mRNA/siRNA, LNP), HPAPIs, and specialty chemicals. SEQENS also operates CELLforCURE, an EMA-authorized CDMO for Advanced Therapy Medicinal Products (ATMPs/Cell & Gene Therapy). The company serves 1,500+ customers in 80+ countries with approximately 2,700 employees and ~1B EUR revenue.

    Key Expertise

    custom API synthesis, HPAPI manufacturing, lipid nanoparticle components (mRNA/siRNA), cell & gene therapy (CELLforCURE), flow chemistry, biocatalysis

    Therapeutic Areas

    Oncology
    Infectious Disease
    Immunology
    Quick Facts
    HQ:Canada
    Employees:2,700
    Capabilities & Services

    Core Capabilities

    • Small Molecule API
    • Formulation Development
    • Cell & Gene Therapy

    Production Scales

    R&D / Pre-clinical
    Lab Scale
    Pilot Scale
    Clinical
    Commercial Scale
    Large Scale (Metric Ton+)

    Annual Capacity

    Small Batch / R&D (< 100 kg/year)
    Medium Clinical (100 - 1,000 kg/year)
    Commercial (1,000 - 10,000 kg/year)
    Large Commercial (> 10,000 kg/year)

    Markets Served

    Europe
    Global
    North America
    Manufacturing Facilities

    5 sites worldwide

    SEQENS - Canada Facility

    Canada
    View on Map

    Site Capabilities

    3 capabilities
    Solid Dose Manufacturing
    Oral Liquids
    Topicals

    SEQENS - Finland Facility

    Finland
    View on Map

    Site Capabilities

    3 capabilities
    Solid Dose Manufacturing
    Oral Liquids
    Topicals

    SEQENS - France Facility

    France
    View on Map

    Site Capabilities

    3 capabilities
    Solid Dose Manufacturing
    Oral Liquids
    Topicals

    SEQENS - Germany Facility

    Germany
    View on Map

    Site Capabilities

    3 capabilities
    Solid Dose Manufacturing
    Oral Liquids
    Topicals

    SEQENS - United States Facility

    United States
    View on Map

    Site Capabilities

    3 capabilities
    Solid Dose Manufacturing
    Oral Liquids
    Topicals
    Certifications

    FDA Registration

    U.S. Food and Drug Administration

    EMA GMP Certificate

    European Medicines Agency
    Request an Introduction

    Please log in to contact this provider.

    Key facts about SEQENS

    • SEQENS is headquartered in Canada.
    • SEQENS has 2,700 employees.
    • SEQENS has 5 manufacturing sites listed on CDMO Hub, in Canada, Finland, France, Germany and the United States.
    • SEQENS's capabilities include Small Molecule API, Formulation Development and Cell & Gene Therapy.

    Find CDMOs like SEQENS

    Directory pages this company appears in, each with the full list of matching manufacturers.

    CDMOs in CanadaCDMOs in North AmericaSmall Molecule API CDMOsFormulation Development CDMOsCell & Gene Therapy CDMOs
    CDMOHUB

    Connecting biotech and pharma teams with contract manufacturing partners worldwide.

    Platform

    • Find CDMOs
    • CDMO Matchmaking
    • Expert Matchmaking
    • SmartRFI
      Members
    • Modality Guides
    • Supplier Maps
    • Join as Partner

    Company

    • Blog
    • Briefings
    • About Us
    • Contact

    Legal

    • Terms of Service
    • Privacy Policy

    © 2026 CDMOHUB. All rights reserved.

    CDMO Hub, Inc. Registered in Delaware, USA